16.03.2017 07-Mar-2017, Moscow.
Pharmstandard, JSC, Russia's leading pharmaceutical company, has established a corporate venture fund, Pharmstandard Ventures, in the form of a new Department. Pharmstandard ventures is going to further develop the portfolio of global biotech investments and open new partnership opportunities for Pharmstandard group.
"We are pleased to welcome the new staff members at Pharmstandard. Working with us as consultants for the past couple of years, this team has already demonstrated outstanding expertise in biotech industry and venture investments. We believe our complementary effort would strengthen Pharmstandard's position as innovation-driven pharma/biotech group" – said GrigoryPotapov, CEO of Pharmstandard.
"We look forward to working together with our colleagues to make the most promising therapeutics and medical technologies available to the patients" – commented Alexey Vinogradov, Head of Pharmstandard Ventures.
Please check www.pharmstd-ventures.com
for further detail.